Delivery Order SPE2DB20D1109-SPE2DB25FN39A

Award Date 1/13/25
Potential Completion Date 1/14/25
Potential Value $2.7K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $10,112.04 and is a firm fixed-price delivery order for the supply of ISOTRETINOIN 40 MG CAPSULE 30S, a pharmaceutical product. The award has an ultimate completion date of January 21, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
The Defense Logistics Agency (DLA) awarded a delivery order contract worth $5,573.52 to Amerisourcebergen Drug Corp's Corporate Office division, a subsidiary of the major pharmaceutical distributor Amerisourcebergen Corporation. The contract is for the delivery of 4,564,388,935 units of the pharmaceutical product ISOTRETINOIN 30 MG CAPSULE 30S, with a completion date of April 25, 2024. This award is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,272.02 firm fixed-price delivery order is for the supply of ISOTRETINOIN 40 MG CAPSULE 30S, a pharmaceutical product. The contract has a period of performance through June 18, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,466.83 Firm Fixed Price Delivery Order is for the supply of 30 mg ISOTRETINOIN capsules, with a completion date of December 5, 2024. This award is not designated under any set-aside program. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves...
This federal contract award, valued at $2,779.20, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is a Delivery Order for 4,566,307,494 units of isotretinoin 30 mg capsules, with a completion date of November 4, 2024. The contract has a Firm Fixed Price pricing type and is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,399.48 firm fixed price delivery order contract is for the supply of 30 mg isotretinoin capsules. The contract has an ultimate completion date of December 11, 2024 and was awarded on December 10, 2024. There is no set-aside designation for this award. AmerisourceBergen holds a $999,999,999 Indefinite Delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,304.77 firm fixed-price delivery order is for the supply of ISOTRETINOIN 30 MG CAPSULE 30S, a generic pharmaceutical product. The contract has an ultimate completion date of October 22, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,020.96 firm fixed-price delivery order is for the supply of Isotretinoin 40 mg capsules, a specialty pharmaceutical product. The contract has an ultimate completion date of October 29, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,093.80 firm fixed-price delivery order is for the supply of 4,566,412,224 units of Isotretinoin 40 mg capsules. The contract has an ultimate completion date of November 14, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,503.54 firm fixed-price delivery order is for the supply of Isotretinoin 30 mg capsules. The contract has an ultimate completion date of October 29, 2024 and was awarded on October 28, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
  • SPE2DB20D1109
    Indefinite Delivery Contract
  • SPE2DB20D1109-SPE2DB25FN39A
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of ISOTRETINOIN 30 MG CAPSULE 30S. The contract has a ceiling value of $2,706.01 and runs through January 14, 2025. It is a Firm Fixed Price Delivery Order contract, with no set-aside designation indicated.

AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, which covers similar medical products and prescription drugs.

Generated 4/21/25, 3:38 AM